Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Patent
1997-10-24
2000-03-21
Azpuru, Carlos A.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
424435, 424443, A61F 1302
Patent
active
060399694
ABSTRACT:
Immune response modifier compounds--imidazoquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, and 1,2-bridged imidazoquinoline amines--are useful for the treatment of TH2 mediated diseases by administering a therapeutically effective amount of such compounds in order to inhibit TH2 immune response, suppress IL-4/IL-5 cytokine induction and eosinophilia, as well as enhance TH1 immune response.
REFERENCES:
patent: 4689338 (1987-08-01), Gerster
patent: 4929624 (1990-05-01), Gerster et al.
patent: 5238994 (1993-08-01), Wick et al.
patent: 5266575 (1993-11-01), Gerster et al.
patent: 5268376 (1993-12-01), Gerster
patent: 5346905 (1994-09-01), Gerster
patent: 5352784 (1994-10-01), Nikolaides et al.
patent: 5389640 (1995-02-01), Gerster et al.
patent: 5395937 (1995-03-01), Nikolaides et al.
patent: 5482936 (1996-01-01), Lindstrom
patent: 5494916 (1996-02-01), Lindstrom et al.
patent: 5525612 (1996-06-01), Gerster
patent: 5767097 (1998-06-01), Tam
Hammerbeck, et al, The Imidazoquinolines and Related Compounds as Inhibitors of Pulmonary Eosinophilia. American Journal of Respiratory and Critical Care Medicine, Apr. 1997, vol. 155, No. 4, part 2.
Varner et al: "Effects of Imiquimod on Post-Viral Asthma-Like Syndrome", J of Allergy and Clinical Immunology, vol. 99, No. 1(2), Jan. 1997, p. s127, XP002055521, Abstract 516.
Hammerbeck David M.
Swingle Karl F.
Tomai Mark A.
3M Innovative Properties Company
Azpuru Carlos A.
Howard MarySusan
Ringsred Ted K.
Sprague Robert W.
LandOfFree
Immune response modifier compounds for treatment of TH2 mediated does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immune response modifier compounds for treatment of TH2 mediated, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immune response modifier compounds for treatment of TH2 mediated will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-728174